OSR HEALTH, INC.
Income Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $2.9M | $3.5M |
| Cost of Revenue | $2.3M | $2.7M |
| Gross Profit | $592.9K | $811.2K |
| Gross Margin | 20.4% | 23.0% |
| Operating Expenses | ||
| Research & Development | $318.4K | $161.2K |
| SG&A Expense | $18.9M | $12.5M |
| Operating Income | $-18.3M | $-11.7M |
| Operating Margin | -631.0% | -331.2% |
| Interest Expense | — | — |
| Pretax Income | $-28.9M | $-11.9M |
| Income Tax Expense | $-1.8M | $-1.6M |
| Net Income | $-27.1M | $-2.4M |
| Net Margin | -931.2% | -68.3% |
| EPS (Basic) | $-0.92 | $-0.48 |
| EPS (Diluted) | $-0.80 | $-0.48 |
| Shares Outstanding (Basic) | 19.5M | 21.6M |
| Shares Outstanding (Diluted) | 22.6M | 21.6M |
| Dividends Per Share | — | — |